谷歌浏览器插件
订阅小程序
在清言上使用

Phase 2 Trial of Pembrolizumab and Olaparib (POLAR) Maintenance for Patients (pts) with Metastatic Pancreatic Cancer (mpdac): Two Cohorts B Non-Core Homologous Recombination Deficiency (HRD) and C Exceptional Response to Platinum-Therapy

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 2|浏览58
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要